ICD-10 Code D57.453 | Sickle-cell thalassemia beta plus with cereb vascular invl Symptoms, Diagnosis, Billing

Sickle-cell thalassemia beta plus with cerebrovascular involvement is a genetic blood disorder characterized by the presence of both sickle cell disease and beta-thalassemia. This condition leads to abnormal hemoglobin production, resulting in sickle-shaped red blood cells that can obstruct blood flow, particularly in the cerebral vasculature. The ICD-10 Code D57.453 is essential for accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.

What is ICD-10 Code D57.453 for Sickle-cell thalassemia beta plus with cereb vascular invl?

ICD-10 Code D57.453 represents Sickle-cell thalassemia beta plus with cerebrovascular involvement, a condition where patients experience complications related to both sickle cell disease and beta-thalassemia. This code should be used in clinical documentation and billing when patients present with symptoms indicative of cerebrovascular complications, ensuring proper treatment and management of this complex condition.

ICD-10 Code D57.453 – Clinical Definition and Explanation of Sickle-cell thalassemia beta plus with cereb vascular invl

Sickle-cell thalassemia beta plus with cerebrovascular involvement is caused by mutations in the HBB gene, leading to the production of abnormal hemoglobin. This condition can progress to severe complications, including stroke, due to the obstruction of blood vessels in the brain. Prompt medical attention is crucial to manage symptoms and prevent further complications.

Key Clinical Features:

• Increased risk of cerebrovascular accidents (strokes)
• Chronic hemolytic anemia
• Painful vaso-occlusive crises
• Increased susceptibility to infections
• Potential for organ damage due to ischemia

ICD-10 Code D57.453 for Sickle-cell thalassemia beta plus with cereb vascular invl – SOAP Notes & Clinical Use

ICD-10 Code D57.453 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, facilitating comprehensive documentation that supports clinical decision-making and billing processes.

What Does ICD-10 Code D57.453 for Sickle-cell thalassemia beta plus with cereb vascular invl Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D57.453 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis. This code plays a vital role in ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D57.453 – Sickle-cell thalassemia beta plus with cereb vascular invl

Hospitalization may be necessary for patients with Sickle-cell thalassemia beta plus with cerebrovascular involvement due to the risk of severe complications. Treatment focuses on managing symptoms and preventing further complications.

Antibiotic Therapy:

• Penicillin prophylaxis for children until age 5
• Ceftriaxone for acute infections
• Alternatives include amoxicillin or azithromycin if allergic

Supportive Care:

• Hydration and pain management
• Blood transfusions for severe anemia
• Regular monitoring for stroke risk

Infection Control:

• Vaccination against pneumococcus, meningococcus, and influenza
• Isolation precautions during acute infections
• Education on hand hygiene and infection prevention

How to Document Symptoms of Sickle-cell thalassemia beta plus with cereb vascular invl (ICD-10 D57.453) in SOAP Notes

Subjective:

• Patient reports recurrent headaches and dizziness.
• History of painful crises requiring emergency care.
• Complaints of fatigue and weakness.
• Family history of sickle cell disease.

Objective:

• Vital signs: BP 120/80, HR 90, Temp 98.6°F.
• Physical exam reveals pallor and jaundice.
• Neurological exam shows no focal deficits.
• Laboratory results indicate low hemoglobin and elevated reticulocyte count.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Sickle-cell thalassemia beta plus with cereb vascular invl (ICD-10 Code D57.453)

Assessment:

• Diagnosis: Sickle-cell thalassemia beta plus with cerebrovascular involvement, moderate severity.
• ICD-10 subcode: D57.453.
• Triggers: Recent infection and dehydration.
• Complications: Risk of stroke and acute chest syndrome.

Plan:

• Initiate hydration therapy and pain management.
• Schedule blood transfusion to address anemia.
• Educate patient on recognizing stroke symptoms.
• Follow-up in one week for reassessment.

Treatment & Plan Section for ICD-10 Code D57.453 – Sickle-cell thalassemia beta plus with cereb vascular invl

• First-line pharmacologic treatments include hydroxyurea to reduce sickling episodes.
• Non-pharmacologic strategies involve lifestyle modifications, such as hydration and avoiding extreme temperatures.
• Monitoring practices include regular hemoglobin checks and neurological assessments.
• Follow-up appointments should be scheduled every 3-6 months to monitor disease progression.

Using ICD-10 Code D57.453 for Sickle-cell thalassemia beta plus with cereb vascular invl in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Commonly billed CPT codes include 36415 for blood transfusion and 99214 for established patient office visits.

Related ICD-10 Codes Often Used with Sickle-cell thalassemia beta plus with cereb vascular invl

• D57.1 – Sickle-cell disease with crisis
• D57.3 – Sickle-cell disease with splenic sequestration

ICD-10 Code D57.453 in Medical Billing and Insurance for Sickle-cell thalassemia beta plus with cereb vascular invl

ICD-10 Code D57.453 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed patient history and clinical findings.
• Use the code in settings where cerebrovascular complications are evident.
• Highlight key chart elements such as lab results and treatment plans to support claims.
• Review coding guidelines to ensure compliance with payer requirements.

Common CPT Pairings: